FOXO4-DRI (FOXO4)
Senolytic peptide (FOXO4-p53 interaction disruptor)
A peptide designed to disrupt the FOXO4-p53 interaction in senescent cells. It is an experimental research compound studied for senolytic ("aging-cell clearing") effects.
Commonly explored for
Verified sellers coming soon
Brands and verified sellers for this compound will appear here as they join the platform.
Educational information only. Peptide 2.0 is an information and marketplace platform, not a pharmacy, and does not make medical claims.